How To Win Corporate Approval For Process Analytical Technologies
Executive Summary
Why Pfizer, Vertex and Biogen executives green-lighted investments in technologies to check seal integrity, ingredient dryness and other process attributes.
You may also be interested in...
Five Companies To Watch At The Jefferies Conference
Novartis and Roche will present alongside up-and-coming biotechs and microcaps.
Pharmaceutical Cost Cutting Seen Hurting Drug Quality
FDA and industry officials say that the current cost-cutting environment is having a negative impact on drug quality, as evident by the record number of drug shortages and recalls. Such cost-cutting, they argue, is shortsighted and not worth the risks of losing jobs or going bankrupt, while investing in PAT and automation may help turn things around.
GMP Oversight Will Have FDA-Wide Coordination Under Rx Quality Council
FDA's newly formed Council on Pharmaceutical Quality will oversee implementation of the agency's pharmaceutical current good manufacturing practices initiative for the 21st century